Leads Biolabs
NanJing, Jiangsu, China
Immunology, Antibody Therapy
1001: LBL-057, a Novel ADCC Enhanced PD-1 Agonist VHH-Fc Antibody
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.